Titan Pharmaceuticals Stock Gross Profit
TTNP Stock | USD 6.88 0.18 2.69% |
Titan Pharmaceuticals fundamentals help investors to digest information that contributes to Titan Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Titan Stock. The fundamental analysis module provides a way to measure Titan Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Titan Pharmaceuticals stock.
Last Reported | Projected for Next Year | ||
Gross Profit | 72 K | 68.4 K | |
Gross Profit Margin | 0.39 | 0.41 |
Titan | Gross Profit |
Titan Pharmaceuticals Company Gross Profit Analysis
Titan Pharmaceuticals' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Titan Pharmaceuticals Gross Profit | (4.37 M) |
Most of Titan Pharmaceuticals' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Titan Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Titan Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for Titan Pharmaceuticals is extremely important. It helps to project a fair market value of Titan Stock properly, considering its historical fundamentals such as Gross Profit. Since Titan Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Titan Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Titan Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition |
According to the company disclosure, Titan Pharmaceuticals reported (4.37 Million) of gross profit. This is 100.19% lower than that of the Pharmaceuticals sector and 100.46% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.02% higher than that of the company.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
All Next | Launch Module |
Titan Fundamentals
Return On Equity | -1.39 | ||||
Return On Asset | -0.75 | ||||
Operating Margin | (39.55) % | ||||
Current Valuation | 95.93 K | ||||
Shares Outstanding | 914.23 K | ||||
Shares Owned By Insiders | 45.46 % | ||||
Shares Owned By Institutions | 5.51 % | ||||
Number Of Shares Shorted | 10.18 K | ||||
Price To Earning | (3.60) X | ||||
Price To Book | 1.00 X | ||||
Price To Sales | 36.07 X | ||||
Revenue | 184 K | ||||
Gross Profit | (4.37 M) | ||||
EBITDA | (7.17 M) | ||||
Net Income | (5.57 M) | ||||
Cash And Equivalents | 6.42 M | ||||
Cash Per Share | 0.44 X | ||||
Total Debt | 565 K | ||||
Debt To Equity | 0.04 % | ||||
Current Ratio | 3.06 X | ||||
Book Value Per Share | 8.50 X | ||||
Cash Flow From Operations | (7.09 M) | ||||
Short Ratio | 0.67 X | ||||
Earnings Per Share | (7.41) X | ||||
Target Price | 7.0 | ||||
Beta | 1.35 | ||||
Market Capitalization | 6.29 M | ||||
Total Asset | 8.09 M | ||||
Retained Earnings | (391.83 M) | ||||
Working Capital | 6.57 M | ||||
Current Asset | 12.24 M | ||||
Current Liabilities | 4.85 M | ||||
Net Asset | 8.09 M |
About Titan Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Titan Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Titan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Titan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Titan Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Titan Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Titan Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Titan Pharmaceuticals Stock:Check out Titan Pharmaceuticals Piotroski F Score and Titan Pharmaceuticals Altman Z Score analysis. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Titan Stock analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Stocks Directory Find actively traded stocks across global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.41) | Revenue Per Share 0.245 | Quarterly Revenue Growth (1.00) | Return On Assets (0.75) | Return On Equity (1.39) |
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.